- Home
- WLGS vs MIRA Comparison
WLGS vs MIRA Comparison
Compare WLGS & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLGS
- MIRA
- Stock Information
- Founded
- WLGS 1981
- MIRA 2020
- Country
- WLGS Hong Kong
- MIRA United States
- Employees
- WLGS N/A
- MIRA N/A
- Industry
- WLGS Engineering & Construction
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- WLGS Consumer Discretionary
- MIRA Health Care
- Exchange
- WLGS Nasdaq
- MIRA Nasdaq
- Market Cap
- WLGS 22.2M
- MIRA 17.1M
- IPO Year
- WLGS 2023
- MIRA 2023
- Fundamental
- Price
- WLGS $2.58
- MIRA $1.05
- Analyst Decision
- WLGS
- MIRA Strong Buy
- Analyst Count
- WLGS 0
- MIRA 2
- Target Price
- WLGS N/A
- MIRA $14.00
- AVG Volume (30 Days)
- WLGS 269.6K
- MIRA 552.1K
- Earning Date
- WLGS 11-14-2024
- MIRA 11-11-2024
- Dividend Yield
- WLGS N/A
- MIRA N/A
- EPS Growth
- WLGS N/A
- MIRA N/A
- EPS
- WLGS N/A
- MIRA N/A
- Revenue
- WLGS $6,825,879.00
- MIRA N/A
- Revenue This Year
- WLGS N/A
- MIRA N/A
- Revenue Next Year
- WLGS N/A
- MIRA N/A
- P/E Ratio
- WLGS N/A
- MIRA N/A
- Revenue Growth
- WLGS 63.69
- MIRA N/A
- 52 Week Low
- WLGS $0.40
- MIRA $0.51
- 52 Week High
- WLGS $4.20
- MIRA $6.40
- Technical
- Relative Strength Index (RSI)
- WLGS 58.66
- MIRA 38.97
- Support Level
- WLGS $2.33
- MIRA $1.04
- Resistance Level
- WLGS $4.20
- MIRA $1.20
- Average True Range (ATR)
- WLGS 0.65
- MIRA 0.07
- MACD
- WLGS 0.04
- MIRA 0.02
- Stochastic Oscillator
- WLGS 34.29
- MIRA 19.44
About WLGS Wang & Lee Group Inc.
WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED (WLHK). WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, and water supply and sewage disposal systems.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.